乐普医疗
(300003)
| 流通市值：182.94亿 | | | 总市值：212.89亿 |
| 流通股本：16.16亿 | | | 总股本：18.81亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,736,231,253.08 | 6,103,269,105.88 | 4,785,471,627.57 | 3,383,886,554.54 |
| 营业收入 | 1,736,231,253.08 | 6,103,269,105.88 | 4,785,471,627.57 | 3,383,886,554.54 |
| 二、营业总成本 | 1,321,825,918.33 | 5,522,118,442.71 | 3,880,756,982.24 | 2,586,484,750.06 |
| 营业成本 | 624,607,361.27 | 2,387,647,101.63 | 1,780,228,328.8 | 1,207,881,959.38 |
| 税金及附加 | 23,165,185.55 | 86,392,279.47 | 58,830,236.87 | 44,492,993.66 |
| 销售费用 | 298,470,737.67 | 1,436,940,700.37 | 973,676,025.69 | 649,472,497.84 |
| 管理费用 | 138,974,325.21 | 799,337,214.54 | 476,245,778.76 | 314,234,119.66 |
| 研发费用 | 203,326,022.08 | 769,557,235.27 | 557,054,487.38 | 356,150,203.71 |
| 财务费用 | 33,282,286.55 | 42,243,911.43 | 34,722,124.74 | 14,252,975.81 |
| 其中:利息费用 | 44,734,185.01 | 180,999,999.83 | 128,195,183.8 | 87,167,026.14 |
| 其中:利息收入 | 21,802,480.09 | 115,513,065.3 | 84,464,783.54 | 58,107,580.3 |
| 加:公允价值变动收益 | 937,293.8 | 389,477.71 | -11,199,598.89 | 7,178,523.94 |
| 加:投资收益 | 19,648,975.2 | -89,713,050.06 | -11,713,964.66 | -19,590,896.79 |
| 资产处置收益 | -385,049.34 | 11,731,723.82 | 12,365,443.28 | 11,847,502.27 |
| 资产减值损失(新) | -2,271,438.27 | -287,867,093.11 | -19,285,127.32 | -18,401,396.19 |
| 信用减值损失(新) | -16,152,446.12 | -56,113,783.9 | -20,531,077.42 | -16,923,707.26 |
| 其他收益 | 52,264,969.51 | 93,561,373.25 | 56,393,787.57 | 40,455,960.53 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 468,447,639.53 | 253,139,310.88 | 910,744,107.89 | 801,967,790.98 |
| 加:营业外收入 | 2,095,149.76 | 13,225,333.92 | 12,077,822.49 | 8,181,536.72 |
| 减:营业外支出 | 5,637,635.19 | 40,603,998.68 | 19,914,620.43 | 14,122,503.19 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 464,905,154.1 | 225,760,646.12 | 902,907,309.95 | 796,026,824.51 |
| 减:所得税费用 | 87,691,140.81 | 28,466,779.07 | 119,559,657.34 | 106,018,680.32 |
| 六、净利润 | 377,214,013.29 | 197,293,867.05 | 783,347,652.61 | 690,008,144.19 |
| 持续经营净利润 | 377,214,013.29 | 197,293,867.05 | 783,347,652.61 | 690,008,144.19 |
| 归属于母公司股东的净利润 | 378,539,846.83 | 246,937,715.5 | 802,655,886.18 | 697,242,271.91 |
| 少数股东损益 | -1,325,833.54 | -49,643,848.45 | -19,308,233.57 | -7,234,127.72 |
| (一)基本每股收益 | 0.21 | 0.13 | 0.43 | 0.38 |
| (二)稀释每股收益 | 0.21 | 0.13 | 0.43 | 0.38 |
| 八、其他综合收益 | 11,828,838.14 | -60,891,593.56 | -9,909,358.96 | -115,074,143.11 |
| 归属于母公司股东的其他综合收益 | 14,710,016.23 | -38,659,869.39 | 7,488,657.4 | -98,317,628.09 |
| 九、综合收益总额 | 389,042,851.43 | 136,402,273.49 | 773,438,293.65 | 574,934,001.08 |
| 归属于母公司股东的综合收益总额 | 393,249,863.06 | 208,277,846.11 | 810,144,543.58 | 598,924,643.82 |
| 归属于少数股东的综合收益总额 | -4,207,011.63 | -71,875,572.62 | -36,706,249.93 | -23,990,642.74 |
| 公告日期 | 2025-04-19 | 2025-04-19 | 2024-10-26 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |